Non-pangenotypic direct-acting antiviral combinations
WHO अत्यावश्यक औषधि EML खण्ड: Non-pangenotypic direct-acting antiviral combinations
लेबल स्थिति: label not available in our sources
यो जानकारी मात्र हो, प्रिस्क्रिप्सन होइन। कुनै पनि औषधि लिनुअघि डाक्टर वा फार्मासिस्टसँग सल्लाह लिनुहोस्। ओभरडोज वा विषाक्तता भए १०२ मा फोन गर्नुहोस्।
Listed for: Non-pangenotypic direct-acting antiviral combinations (WHO EML section heading).
What is Ledipasvir/sofosbuvir used for?
It is listed for: Non-pangenotypic direct-acting antiviral combinations (WHO Model List section).
Is Ledipasvir/sofosbuvir an essential medicine?
Yes, it is on the WHO Model List of Essential Medicines.
What is the dose of Ledipasvir/sofosbuvir?
Not provided here. Ask a doctor or pharmacist.
Ledipasvir/sofosbuvir के हो?
Ledipasvir/sofosbuvir is an essential medicine on the WHO Model List, listed under: Non-pangenotypic direct-acting antiviral combinations. A product label is not available in our sources.
स्रोत: WHO Model List of Essential Medicines, 23rd list (2023) · Reference · Reference
WHO Model List of Essential Medicines, 23rd list (2023), World Health Organization